Cyclarity Therapeutics advances to clinical stage with first-in-human trial
Biospace - 08-Jan-2025A groundbreaking step toward disease-modifying treatments for cardiovascular care
Biospace
Digital hub for life science news and careers
BioSpace is a digital hub for news and careers for life science professionals. It provides essential insights, opportunities and tools to connect the innovative organizations and talented professionals who advance health and quality of life across the globe.
Visit website: https://www.biospace.com/
Details last updated 12-Apr-2021
People at Biospace
Articles sourced from Biospace
ADx NeuroSciences partners with Alamar Biosciences to advance neurodegenerative assays
Biospace - 28-Oct-2024Together, they aim to provide pharmaceutical companies with precise tools for drug development
Rejuvenate Bio partners with animal company to develop gene therapy for canine osteoarthritis
Biospace - 14-Feb-2024Single dose injection targets root causes, offering long-term relief & improved quality of life
Gallant Therapeutics snags $15M to develop stem cell therapies for pets
Biospace - 08-Jan-2024Focused on regenerative treatments for feline gingivitis, canine arthritis, and more
ARCUS gene editing technology effectively eliminates mutant mitochondrial DNA
Biospace - 04-Dec-2023Potential therapeutic approach for mitochondrial and other genetic diseases
Personalised cell therapy for Parkinson's receives FDA fast track designation
Biospace - 19-Oct-2023Aspen Neuroscience's ANPD001 aims to replace lost neurons and improve motor function
UNITY Biotech's lead compound lags behind the Regeneron’s eye drug
Biospace - 27-May-2023UBX1325 showed disappointing results in phase II macular degeneration trial - further analysis is required
Thymmune Therapeutics raised $7 million in seed financing
Biospace - 02-Mar-2023Thymmune aims at developing therapies to treat several autoimmune diseases and organ transplant tolerance
Chroma secures new investment of 135M for Series B in genetic medicines
Biospace - 01-Mar-2023Epigenetic medicine approach avoids the pitfalls of traditional CRISPR method of gene editing
Jeune Aesthetics moves to the Phase 2 trial for fine lines and wrinkles
Biospace - 17-Nov-2022Targeted gene-delivery hold potential in replenishing the skins key protein, to treat fine lines
Juvena Therapeutics receives $50M to uncover therapeutic links between secreted proteins and diseases
Biospace - 08-Nov-2022Its a fully integrated approach for developing biologics for chronic and age-related diseases
$72m funding launching Pretzel Therapeutics pioneering mitochondrial therapies
Biospace - 12-Sep-2022Pretzel targets genome correction, genome expression modulation and mitochondrial quality control
Turn Bio raised funds to usher epigenetic reprogramming from bench to bedside
Biospace - 11-Apr-2022mRNA technology-reset aging to extend health span and improve quality of life
Retro Biosciences launched to add 10 years to human lifespan
Biospace - 06-Apr-2022$180M fund will support research on cellular reprogramming, autophagy & plasma-inspired therapeutics
1E Therapeutics raised $120M seed funding to develop RNA-targeting therapies
Biospace - 09-Dec-2021Biotech experts back 1E, believing it can transform medical treatments
RPE-Cell therapy might potentially prevent blindness in dry AMD
Biospace - 14-Jun-2021Lineage CEO says “it offers a whole new paradigm to treat the disease”
RepliCel contracts Accerise to plan phase 2 cell therapy trials in Japan
Biospace - 19-May-2021Successful trial results could bring us skin rejuvenation & tendon regeneration products
FDA grants Endogena's primary program for EA-2353 suspension targeting retinitis pigmentosa
Biospace - 13-May-2021Endogena’s photoreceptor regeneration approach offers new treatment paradigm in retinitis pigmentosa
BioViva tests experimental telomerase gene-therapy in 6 Alzheimer's patients
Biospace - 03-May-2021Launched home test to track biological age; outcomes of unlicensed gene-therapy are yet to report
Maxwell Biosciences secures funding to develop powerful new antiviral drug
Biospace - 06-Apr-2021The drugs also showed high safety in human tissue and animal studies
Genentech and Genesis Therapeutics join forces for AI-powered drug discovery
Biospace - 19-Oct-2020The biotech’s AI platform aims to unlock new treatments for severe diseases
Bit Bio secures $41.5 M funding to produce human cells
Biospace - 15-Jun-2020UK-based startup reprogramming stem cells to generate new cell therapies
Alector’s AL002 shows early promise in Alzheimer’s treatment
Biospace - 09-Dec-2019First-in-human trial demonstrates safety and brain-target engagement for TREM2 therapy
CuraSen secures $54m to combat neurodegenerative diseases
Biospace - 17-Oct-2018Targeting brain function to address Parkinson’s and Alzheimer’s at their core
Alector raises 133 million to tackle neurodegenerative diseases
Biospace - 25-Jul-2018Advancing immune-based therapies for alzheimer’s and dementia
AI innovation tackles early Alzheimer’s detection
Biospace - 09-Aug-2017How MyndYou's speech-tracking technology is transforming diagnostics and care
